UK Companies House feature
NICHE GENERICS LIMITED
Cash
£340K
-32% vs 2024
Net assets
-£748K
-107.9% vs 2024
Employees
53
-5.4% vs 2024
Profit before tax
-£388K
-169.8% vs 2024
Profile
- Company number
- 04353309
- Status
- Active
- Incorporation
- 2002-01-15
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Net assets
7-year trend · vs UK Healthcare median
Accounts
7-year trend · latest 2025-03-31
| Metric | Trend | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | £8,253,199 | — | — | — | — | — | |
| Operating profit | — | -£314,948 | — | — | — | — | — | |
| Profit before tax | — | £3,170,530 | — | — | — | £556,224 | -£388,077 | |
| Net profit | — | £3,170,530 | — | — | — | £556,224 | -£388,077 | |
| Cash | — | £480,923 | — | — | — | £499,639 | £339,988 | |
| Total assets less current liabilities | — | £400,152 | — | — | — | £2,194,568 | -£747,587 | |
| Net assets | — | — | — | — | — | -£359,510 | -£747,587 | |
| Equity | -£4,270,378 | £400,152 | £487,512 | £72,407 | -£915,734 | -£359,510 | -£747,587 | |
| Average employees | — | — | — | — | — | 56 | 53 | |
| Wages | — | — | — | — | — | — | £2,787,507 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- HW Fisher Audit
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“We draw attention to note 1.2 in the financial statements which describes the potential impact of the on-going litigation and the company's reliance on the financial support of its parent company. These events and conditions indicate that a material uncertainty exists that may cast significant doubt on the company's ability to continue as a going concern. Our opinion is not modified in respect of this matter.”
Significant events
- “A fine of just under €14m has been imposed by the European Commission that the company is exposed to jointly and severally with its parent company.”
- “following the failure of appeals against the EU Commission judgements Laboratories Servier is being sued by the UK Health Authorities. Laboratories Servier has, during the year, filed a Part 20 claim against the company comp for a contribution towards any damages awarded to UK Health Authorities.”
- “On 28 March 2025, the company's parent company announced their intention to close the manufacturing facility.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MOSS, Christopher | Secretary | 2002-04-05 | — | British |
| GODHA, Pranaya | Director | 2023-09-13 | Mar 1972 | Indian |
| JAIN, Manish Kumar | Director | 2025-11-25 | Oct 1974 | Indian |
| MOSS, Christopher | Director | 2007-06-04 | Dec 1970 | British |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| LAWSON (LONDON) LIMITED | Corporate Nominee Secretary | 2002-01-15 | 2002-04-05 |
| ANSELL, Geoffrey Raymond | Director | 2002-04-15 | 2006-12-14 |
| ASHWORTH, Stuart | Director | 2007-06-04 | 2007-11-12 |
| COLE, Gerard Majella | Director | 2007-03-05 | 2025-10-30 |
| FOSTER, Lynda | Director | 2002-04-15 | 2006-12-14 |
| GRAHAM, Maureen, Dr | Director | 2004-04-26 | 2005-10-24 |
| JOSEPHS, John Alexander | Director | 2002-04-15 | 2006-12-14 |
| KUNKOLIENKAR, Dilip Janardan | Director | 2018-11-16 | 2023-08-10 |
| LAMBA, Rajeev Kumar | Director | 2002-04-15 | 2007-06-04 |
| MODY, Prakash, Doctor | Director | 2002-04-15 | 2013-10-10 |
| MOSS, Christopher | Director | 2002-04-05 | 2006-12-14 |
| PARIKH, Rakesh | Director | 2002-04-15 | 2007-06-04 |
| SHAH, Jayendra | Director | 2002-04-15 | 2007-06-04 |
| SHAH, Prafull Anubhai | Director | 2004-04-26 | 2007-06-04 |
| SHARMA, Bhoopendra Kumar | Director | 2002-04-05 | 2018-11-16 |
| ACRE (CORPORATE DIRECTOR) LIMITED | Corporate Nominee Director | 2002-01-15 | 2002-04-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Unichem Laboratories Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 112 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-14 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2026-03-27 | CH01 | officers | change person director company with change date |
| 2026-03-20 | AP01 | officers | appoint person director company with name date |
| 2025-11-17 | AA | accounts | accounts with accounts type full |
| 2025-10-30 | TM01 | officers | termination director company with name termination date |
| 2025-01-27 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-11-12 | AA | accounts | accounts with accounts type full |
| 2024-02-01 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-12-05 | AA | accounts | accounts with accounts type full |
| 2023-09-14 | AP01 | officers | appoint person director company with name date |
| 2023-08-22 | TM01 | officers | termination director company with name termination date |
| 2023-02-02 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-11-25 | AAMD | accounts | accounts amended with accounts type full |
| 2022-11-22 | AA | accounts | accounts with accounts type total exemption full |
| 2022-01-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-06-04 | AA | accounts | accounts with accounts type full |
| 2021-01-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-12-08 | AA | accounts | accounts with accounts type full |
| 2020-02-06 | CS01 | confirmation-statement | confirmation statement with updates |
| 2019-11-20 | AA | accounts | accounts with accounts type full |
Credit score
Altman Z″ (private-firm) · reference 2025-03-31
-1.77
DISTRESS
Altman Z″
- Working capital / Total assets -0.204 × 6.56 = -1.34
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets -0.046 × 6.72 = -0.31
- Book equity / Total liabilities -0.120 × 1.05 = -0.13
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory